|
1
|
Sarris A, Dimopoulos M, Pugh W and
Cabanillas F: Primary lymphoma of the prostate: good outcome with
doxorubicin-based combination chemotherapy. J Urol. 153:1852–1854.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liguori G, Amodeo A, Mucelli FP, et al:
Intractable haematuria: long-term results after selective
embolization of the internal iliac arteries. BJU Int. 106:500–503.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abt D, Bywater M, Engeler DS and Schmid
HP: Therapeutic options for intractable hematuria in advanced
bladder cancer. Int J Urol. 20:651–660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rastinehad AR, Caplin DM, Ost MC, et al:
Selective arterial prostatic embolization (SAPE) for refractory
hematuria of prostatic origin. Urology. 71:181–184. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zuazu JR, Iglesias R, Costa DR, et al:
Prostatic lymphoma and review of the literature. Actas Urol Esp.
33:686–690. 2009.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan B, Han JK, Wang SC and Xu A: Positron
emission tomography/computerized tomography in the evaluation of
primary non-Hodgkin’s lymphoma of prostate. World J Gastroenterol.
19:6699–6702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bostwick DG, Iczkowski KA, Amin MB,
Discigil G and Osborne B: Malignant lymphoma involving the
prostate: Report of 62 cases. Cancer. 83:732–738. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mikhaeel NG, Hutchings M, Fields PA,
O’Doherty MJ and Timothy AR: FDG-PET after two to three cycles of
chemotherapy predicts progression-free and overall survival in
high-grade non-Hodgkin lymphoma. Ann Oncol. 16:1514–1523. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao J, Qiao W, Wang C, Wang T and Xing Y:
Therapeutic evaluation and prognostic value of interim hybrid
PET/CT with (18)F-FDG after three to four cycles of chemotherapy in
non-Hodgkin’s lymphoma. Hematol. 12:423–430. 2007. View Article : Google Scholar
|
|
10
|
Jhavar S, Agarwal JP, Naresh KN,
Shrivastava SK, Borges AM and Dinshaw KA: Primary extranodal mucosa
associated lymphoid tissue (MALT) lymphoma of the prostate. Leuk
Lymphoma. 41:445–449. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fisher RI, Gaynor ER, Dahlberg S, et al:
Comparison of a standard regimen (CHOP) with three intensive
chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J
Med. 328:1002–1006. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Csomor J, Kaszás I, Kollár B, et al:
Prolonged survival using anti-CD20 combined chemotherapy in primary
prostatic intravascular large B-cell lymphoma. Pathol Oncol Res.
14:281–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feugier P, Van Hoof A, Sebban C, et al:
Long-term results of the R-CHOP study in the treatment of elderly
patients with diffuse large B-cell lymphoma: a study by the Groupe
d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 23:4117–4126.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lupu A, Radu P, Pană B and Kalfas C:
R-CHOP vs. CHOP: A cost-effectiveness analysis on aggressive
non-Hodgkin’s lymphoma (NHL). Management in Health. 13:18–21. 2009.
View Article : Google Scholar
|
|
15
|
Coiffier B, Lepage E, Briere J, et al:
CHOP chemotherapy plus rituximab compared with CHOP alone in
elderly patients with diffuse large-B-cell lymphoma. N Engl J Med.
346:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hald T and Mygind T: Control of
life-threatening vesical hemorrhage by unilateral hypogastric
artery muscle embolization. J Urol. 112:60–63. 1974.PubMed/NCBI
|
|
17
|
Kato T, Sato K, Sasaki R, Kakinuma H and
Moriyama M: Targeted cancer chemotherapy with arterial microcapsule
chemoembolization: review of 1013 patients. Cancer Chemother
Pharmacol. 37:289–296. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ozono S, Kim S, Takashima K, et al:
Intra-arterial chemotherapy for invasive bladder cancer. Hinyokika
Kiyo. 45:133–137. 1999.(In Japanese). PubMed/NCBI
|
|
19
|
Fukutani K, Koyama Y, Fujimori M and
Ishida T: Primary malignant lymphoma of the prostate: report of a
case achieving complete response to combination chemotherapy and
review of 22 Japanese cases. Nihon Hinyokika Gakkai Zasshi.
94:621–625. 2003.(In Japanese). PubMed/NCBI
|
|
20
|
Ferraris AM, Giuntini P and Gaetani GF:
Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin
lymphomas. Blood. 54:928–932. 1979.PubMed/NCBI
|
